Concas A, Santoro G, Serra M, Sanna E, Biggio G
Department of Experimental Biology, University of Cagliari, Italy.
Brain Res. 1991 Mar 1;542(2):225-32. doi: 10.1016/0006-8993(91)91571-h.
The effect of propofol, a novel short acting anaesthetic, on the function of the GABAA/ionophore receptor complex was studied in vitro in cortical membrane preparations from rat cerebral cortex and was compared with the action of pentobarbital and alphaxalone, two general anaesthetics known to enhance GABAergic transmission. Propofol, mimicking the action of pentobarbital and alphaxalone, increased [3H]GABA binding, reduced [35S]TBPS binding and enhanced muscimol-stimulated 36Cl- uptake in a concentration-dependent manner. While the efficacy of the drugs in affecting these biochemical parameters was similar, they differed markedly in potency being alphaxalone greater than propofol greater than pentobarbital. However, separate sites of action or different mechanisms for these drugs can be suggested by the result that the concomitant addition of propofol either with alphaxalone or pentobarbital or diazepam produced a simple additive inhibition of [35S]TBPS binding as well as an additive enhancement of [3H]GABA binding and muscimol-stimulated 36Cl- uptake. The effect of propofol at the level of the GABA/ionophore receptor complex seems to be strictly dependent on the interaction of GABA with its recognition site. In fact, the specific GABAA receptor antagonist bicuculline antagonized the decrease of [35S]TBPS binding as well as the enhancement of [3H]GABA binding and muscimol-stimulated 36Cl- uptake induced by propofol. On the other hand, propofol was able to enhance [3H]GABA binding in membranes previously incubated with the specific chloride channel blocker picrotoxin. Finally, the finding that propofol fails to affect [3H]flunitrazepam binding together with the failure of Ro 15-1788 and PK 11195 to antagonize its effect on [35S]TBPS binding excludes a direct interaction at the level of benzodiazepine recognition sites.(ABSTRACT TRUNCATED AT 250 WORDS)
在体外对大鼠大脑皮质的皮质膜制剂进行研究,探讨新型短效麻醉药丙泊酚对GABAA/离子载体受体复合物功能的影响,并将其与戊巴比妥和alphaxalone这两种已知可增强GABA能传递的全身麻醉药的作用进行比较。丙泊酚模拟戊巴比妥和alphaxalone的作用,以浓度依赖的方式增加[3H]GABA结合、减少[35S]TBPS结合并增强蝇蕈醇刺激的36Cl-摄取。虽然这些药物影响这些生化参数的效力相似,但它们的效价差异显著,alphaxalone大于丙泊酚大于戊巴比妥。然而,丙泊酚与alphaxalone、戊巴比妥或地西泮同时添加会对[35S]TBPS结合产生简单的相加抑制作用,同时对[3H]GABA结合和蝇蕈醇刺激的36Cl-摄取产生相加增强作用,这一结果提示这些药物存在不同的作用位点或不同的作用机制。丙泊酚在GABA/离子载体受体复合物水平的作用似乎严格依赖于GABA与其识别位点的相互作用。事实上,特异性GABAA受体拮抗剂荷包牡丹碱可拮抗丙泊酚诱导的[35S]TBPS结合减少以及[3H]GABA结合和蝇蕈醇刺激的36Cl-摄取增强。另一方面,丙泊酚能够增强先前用特异性氯离子通道阻断剂印防己毒素孵育的膜中的[3H]GABA结合。最后,丙泊酚未能影响[3H]氟硝西泮结合,以及Ro 15-1788和PK 11195未能拮抗其对[35S]TBPS结合的作用,这一发现排除了在苯二氮䓬识别位点水平的直接相互作用。(摘要截短于250字)